Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

But beware: this maze is designed to startle and confuse, leaving you questioning your sense of direction! Feeling brave? Take it up a notch by trying to navigate the maze in Dark Mode.

or you might get lost forever. Open a book or two and start to strategize the best route. Just kidding, all you need to do is click your mouse, and your avatar will do all the walking in the Maze ...

Publisher Alliance Arts and developer Unknown X will release a PlayStation 4 version of Touhou Project rhythm game Touhou Danmaku Kagura: Phantasia Lost on April 16, the companies announced.

The friend asks if he intends to become a Protestant. “I said that I had lost the faith,” Stephen responds, “but not that I had lost selfrespect. What kind of liberation would that be to ...

Maze seeks as much as $133 mln in New York IPO Backers include Alphabet's GV and Third Rock Ventures Biotech IPOs set for ramp up in coming weeks Jan 27 (Reuters) - Drug developer Maze ...

Elon Musk-owned social network X announced a partnership with Visa to handle person-to-person payments for its upcoming X Money product. The company will use Visa Direct, which is Visa’s ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

Jan 31 (Reuters) - Maze Therapeutics (MAZE.O), opens new tab became the latest drug developer to list in New York on Friday, with its shares rising nearly 1% in their debut, giving the company a ...

Visa is the first partner for X Money accounts, which X says will support instant bank transfers and P2P payments. Visa is the first partner for X Money accounts, which X says will support ...